FDS · Factset Research Systems Inc
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted diluted EPS non-GAAP | $4.53 | Q3 FY2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Diluted EPS $3.5
+$0.4 Intangible asset amortization
+$0.42 Restructuring/severance
+$0.09 CEO compensation costs
+$0.04 Business disposition, acquisitions and related costs
+$0.06 Impairment within Other assets
+$0.02 Client bankruptcy charges
+$0 Non-operating income from business disposition
= Adjusted diluted EPS $4.53
|
|||
| Adjusted EBITDA non-GAAP | 220.17M | Q3 FY2026 | — |
|
|
|||
| Adjusted operating margin non-GAAP | 34% | Three Months Ended May 31, 2026 | — |
|
|
|||
| ASV from Asia Pacific | 255.2M | May 31, 2026 | — |
| ASV from EMEA | 608.1M | May 31, 2026 | — |
| ASV from the Americas | 1.62B | May 31, 2026 | — |
| Client count | 9,100 | Q3 FY2026 | — |
|
|
|||
| Free cash flow non-GAAP | 254M | Q3 FY2026 | — |
|
|
|||
| Organic ASV non-GAAP | 2.49B | Q3 FY2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP As reported ASV 2.48B
+1.3M Impact from foreign currency movements
= Organic ASV 2.49B
|
|||
| Organic ASV annual growth rate non-GAAP | 7.1% | As of May 31, 2026 | — |
| Organic ASV from Asia Pacific non-GAAP | 255.9M | May 31, 2026 | — |
| Organic ASV from EMEA non-GAAP | 608.7M | May 31, 2026 | — |
| Organic ASV from the Americas non-GAAP | 1.62B | May 31, 2026 | — |
| Organic revenues non-GAAP | 622.87M | Three Months Ended May 31, 2026 | — |
|
|
|||
| Remaining share repurchase authorization | 494M | May 31, 2026 | — |
| Shares repurchased | 926,370 | Q3 FY2026 | — |
| User count | 247,000 | Q3 FY2026 | — |
|
|
|||
| Adjusted net income non-GAAP | 165.27M | Q2 FY2026 | — |
GAAP → non-GAAP reconciliationGAAP Net income 133.06M
+15.12M Intangible asset amortization
+10.25M Impairment within Other assets
+3.11M CEO compensation costs
+2.27M India labor codes reform
+1.61M Business disposition, acquisitions and related costs
+699K Asset impairment
+135K Restructuring/severance
-130K Non-operating income from business disposition
-852K Income tax items
= Adjusted net income 165.27M
|
|||
| Adjusted operating income non-GAAP | 214.07M | Q2 FY2026 | — |
GAAP → non-GAAP reconciliationGAAP Operating income 184.96M
+19.18M Intangible asset amortization
+3.94M CEO compensation costs
+2.88M India labor codes reform
+2.04M Business disposition, acquisitions and related costs
+887K Asset impairment
+171K Restructuring/severance
= Adjusted operating income 214.07M
|
|||
| Annual client retention | 91% | Q2 FY2026 | — |
| Annual Subscription Value (ASV) | 2.45B | Q2 FY2026 | — |
| EBITDA non-GAAP | 217.86M | Three Months Ended February 28, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net income 133.06M
+13.06M Interest expense
+28.06M Income taxes
+43.69M Depreciation and amortization expense
= EBITDA 217.86M
|
|||
| Employee headcount | 12,840 | Q2 FY2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Financial Data & Stock Exchanges — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
FDS
this stock
Factset Research Systems Inc
|
$10.99B | +6.5% | +6.3% | 20.4 | 10.1% |
|
SPGI
S&P Global Inc.
|
$138.57B | — | +7.1% | 29.6 | 2.4% |
|
CME
Cme Group Inc.
|
$102.77B | +4.7% | +6.4% | 24.2 | 1.4% |
|
ICE
Intercontinental Exchange, Inc.
|
$91.13B | +0.2% | -2.1% | 22.9 | 1.4% |
|
MCO
Moodys Corp /De/
|
$89.19B | +0.8% | +16.6% | 32.7 | 1.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| FDS | +3.0% | +17.4% | +39.8% | +17.4% | +6.5% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | +2.6% | +14.4% | +26.4% | +14.4% | -6.3% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.